QUOTE AND NEWS
Shocked Investor  1 hr ago  Comment 
We track the companies that make H1N1-related produts on this site. The top performer year-to-date is BCRX (Biocryst), with a staggering return of 723%, followed by SVA (Sinovac), +492%. At least here in Canada, the few H1N1 deaths have been well...
New York Times  Nov 6  Comment 
Peramivir might also be a life saver for its developer, BioCryst Pharmaceuticals, an unprofitable biotechnology company in Birmingham, Ala.
TheStreet.com  Nov 5  Comment 
Sorting out the latest salvo in the H1N1 investor war
StreetInsider.com  Nov 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/FDA/BioCryst+%28BCRX%29+Jumps+Higher+After+Canceling+Conference+Appearance/5074920.html for the full story.
StreetInsider.com  Nov 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/FDA/BioCryst+%28BCRX%29+Partner+In+Japan+Files+NDA+for+Peramivir/5073515.html for the full story.
PR Newswire  Oct 29  Comment 
BIRMINGHAM, Ala., Oct. 29 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Jon P. Stonehouse, President and Chief Executive Officer of BioCryst, and Stuart Grant, Chief Financial Officer of BioCryst, plan
TheStreet.com  Oct 28  Comment 
Details emerge on emergency use of peramivir for H1N1 patients.
FX Street  Oct 28  Comment 
Harry Boxer, On Long & Short Charts to Watch (TheTechTrader.com) We're experiencing a volatile market here, and both longs and shorts are possibilities, so today we're going to give you ideas on both sides. The flu-related stocks certainly had...
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
BCRX AT A GLANCE
P/E -28.7 
EV/EBITDA -32.8 
ROA -19.6%AVG
ROE -45.9%AVG
Debt to Equity 1.07AVG
Current Ratio 4.27AVG
 
 
 
 
 
 
 
 



References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki